Real-World Evidence - What Is It and What Can It Tell Us?
about
Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries?21st Century Cures Bill May Lead To Faster Drug/Device Approvals: But Moving Away from Clinical Trials Worries SomeEffectiveness of a Timing and Coordination Group Exercise Program to Improve Mobility in Community-Dwelling Older Adults: A Randomized Clinical Trial.Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose CotEffectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical dataNetwork analysis of surgical innovation: Measuring value and the virality of diffusion in robotic surgery.When and how can real world data analyses substitute for randomized controlled trials?Real-world research and the role of observational data in the field of gynaecology - a practical review.Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China.Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration.Pragmatic (trial) informatics: a perspective from the NIH Health Care Systems Research Collaboratory.Accelerating development of scientific evidence for medical products within the existing US regulatory framework.A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus.New treatment directions for IPF: current status of ongoing and upcoming clinical trials.Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area.17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies.Assessing advances in regional anesthesia by their portrayals in meta-analyses: an alternative view on recent progress.Precision medicine: In need of guidance and surveillance.In the Real-World, Kids Use Medications and Devices.The Range and Scientific Value of Randomized Trials.Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals.Registries supporting new drug applications.Improving Realism in Clinical Trial Simulations via Real-World Data.Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: The metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study).Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.Real-world evidence on clinical and economic outcomes of switching to insulin glargine 300 Units/mL vs other basal insulins in patients with type 2 diabetes on basal insulin.High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO).Pharmacoepidemiology in the era of real-world evidence.Use of Health Care Databases to Support Supplemental Indications of Approved Medications.The implementation of academic detailing and its effectiveness on appropriate prescribing of pain relief medication: a real-world cluster randomized trial in Belgian general practices.Caution needed in introduction of provisional approvals for medicines.Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.Leveraging Big Data in Pediatric Development Programs: Proceedings From the 2016 American College of Clinical Pharmacology Annual Meeting Symposium.Using oncology real-world evidence for quality improvement and discovery: the case for ASCO's CancerLinQ.Real-World Evidence, Public Participation, and the FDA.A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making.
P2860
Q36373945-590051EF-C091-476E-865E-175669F2D0CDQ36404862-43E5306A-07F4-47F5-9218-CEA55AEBE6BBQ37605295-83A28CC2-9962-4F9B-A551-5AF43FA530F6Q38372233-81201863-8C65-448C-A310-4F4B479C7D8DQ38376619-F0DCD168-5302-4DB9-BDD4-2D331D93C08DQ38597546-2111914D-03A5-4828-9828-E58590DCFBDEQ38608136-7FEDCB39-2F26-41CB-9F06-A571E674A7FEQ38610846-3C0D6B2C-F528-4D7D-A289-CEFE264EC8E6Q38619701-C0032F38-1B08-4FEB-B421-9ACEC9A748ECQ38629753-6DA06671-73B0-4C9C-AC7D-38F9D3B6E217Q38712425-581623BC-EEB4-4DAD-BC55-CDF9060DFBD2Q38740187-BC1CCD76-F403-4514-B141-D75E4595D54AQ38945109-4E8D0749-FD89-4BC7-8869-33C28B39DD4EQ39255188-90376D78-3F68-48B7-86A7-1555B1961234Q39330304-3384D6C7-3820-42CE-B3DB-563EF3A8A4A4Q40108064-7B5C0E38-E748-46D3-BA57-68BA72489D5CQ40325008-CD019FE6-F47A-47A4-9237-5CE11E865DE9Q40996798-C52A9DC7-506C-4FB7-973E-4499FEA40FE7Q41558563-778BEFDA-136D-4CC6-9FAE-F17EC1AD97F3Q42340386-E0F32DF1-2B0D-451B-B708-A9533B539D28Q42343028-8EB48BE9-89E9-4AA9-81C0-88512E51E18BQ42379773-0FE9D5F0-F3F6-4C80-AC0B-30D15167DC7CQ42702410-721C35A4-33DE-4620-9D2F-3736E3B7A562Q45934058-71A95CC5-79BE-4B90-A682-1D1FBEB783FCQ47102430-12EE29BA-3F9F-45F5-A5D7-B99E91E97A6CQ47150754-BA4BDA0C-CB68-4185-B4EF-F8D697C5BD60Q47190358-5A99ACD6-BA0E-434D-87A5-76E46707AFA6Q47215717-714229B0-F3FA-408D-8781-F80F2773E4D0Q47250841-4682CC44-F13C-4ED7-8476-F12F8837354AQ47259503-6B04F58E-C655-4E17-B132-35059F64E89DQ47282148-479E131B-1D96-4B92-BE76-C9341A8374A0Q47369866-465E02A6-CA0D-418D-A500-A403AA929F97Q47438084-ED694BC3-7759-4DCC-B879-8658095516E0Q47562766-AEEF91C0-402E-489D-A396-8BC09020AD7EQ47565837-ED44B29B-37AE-45A8-BDFC-03A745B17549Q47657221-0D1C2A24-D30C-4122-AFA3-2A13ED7FAE01Q47741125-FC37A48C-67CE-460A-8312-53C5CC793A63Q47755168-ED406C8A-0D0C-4501-8972-A6F78AB3D16DQ47820443-5C632DC0-3CBE-42BC-9F43-2A7A52A9AEBDQ48256303-90DD662A-9070-404C-863C-F559F08349C2
P2860
Real-World Evidence - What Is It and What Can It Tell Us?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Real-World Evidence - What Is It and What Can It Tell Us?
@en
type
label
Real-World Evidence - What Is It and What Can It Tell Us?
@en
prefLabel
Real-World Evidence - What Is It and What Can It Tell Us?
@en
P2093
P356
P1476
Real-World Evidence - What Is It and What Can It Tell Us?
@en
P2093
Danica Marinac-Dabic
Gerald J Dal Pan
Gerry W Gray
Janet Woodcock
Jeffrey Shuren
Lilly Q Yue
Lisa LaVange
Melissa A Robb
Nina L Hunter
Peter W Marks
P304
P356
10.1056/NEJMSB1609216
P407
P577
2016-12-01T00:00:00Z